(HealthDay News) – Low nutritional assessment scores, poor mobility, and advanced disease predict early death after chemotherapy initiation among elderly patients with cancer.
To investigate factors that predict death within six months of chemotherapy initiation, Pierre Soubeyran, MD, PhD, of the Bordeaux Segalen University in France, and colleagues studied 348 elderly cancer patients (median age, 77.45 years) who had not had previous cancer treatment. Participants were evaluated at baseline using the abbreviated comprehensive geriatric assessment (aCGA), including the Mini-Mental State Exam, Timed Get Up and Go (GUG), Activities of Daily Living (ADL), Instrumental Activities in Daily Living (IADL), Mini Nutritional Assessment (MNA), Geriatric Depression Scale (GDS15), and comorbidities index (Cumulative Index Rating Scale-Geriatric).
The researchers found that 18.1% of participants had abnormal aCGA scores on the ADL, as did 73% on the IADL, 24.1% on the GUG, 19% on the MMS, 44% on the GDS15, and 64.9% on the MNA. Higher risk of early death was associated with advanced disease (odds ratio [OR], 3.9), a low MNA score (OR, 2.77), male gender (OR, 2.4), and long GUG (OR, 2.55).
“We recommend that the MNA and GUG, performed by a trained nurse, be maintained as part of routine pretreatment work-up in these patients to identify at-risk patients and to inform the decision-making process for chemotherapy,” the authors write.
Several authors disclosed financial relationships with pharmaceutical companies, many of which funded the study.